切换至 "中华医学电子期刊资源库"

中华乳腺病杂志(电子版) ›› 2007, Vol. 01 ›› Issue (02) : 32 -35. doi: 10.3877/cma.j.issn.978-7-900220-07-3.2007.02.011

综述

IL-1β 与肿瘤转移关系的研究进展
崔力方1, 陈凌1, 付丽1,()   
  1. 1.300060 天津医科大学附属肿瘤医院乳腺病理科、教育部乳腺癌研究重点实验室
  • 收稿日期:2006-11-30 出版日期:2007-02-25
  • 通信作者: 付丽
  • 基金资助:
    国家自然科学基金资助项目(30470667)

Advancement of the relation of IL-1β with tumor metastasis

Li-fang CUI, Ling CHEN, Li FU()   

  • Received:2006-11-30 Published:2007-02-25
  • Corresponding author: Li FU
引用本文:

崔力方, 陈凌, 付丽. IL-1β 与肿瘤转移关系的研究进展[J/OL]. 中华乳腺病杂志(电子版), 2007, 01(02): 32-35.

Li-fang CUI, Ling CHEN, Li FU. Advancement of the relation of IL-1β with tumor metastasis[J/OL]. Chinese Journal of Breast Disease(Electronic Edition), 2007, 01(02): 32-35.

[1]
Dinarello C A. Interleukin-1 beta. Crit Care Med,2005,33:S460-462.
[2]
Apte R N, Voronov E. Interleukin-1—a major pleiotropic cytokine in tumor-host interactions. Semin Cancer Biol,2002,12:277 -290.
[3]
Macri A, Versaci A, Loddo S,et al. Serum levels of interleukin-1 beta, interleukin 8 and tumour necrosis factor alpha as markers of gastric cancer. Biomarkers,2006,11:184 -193.
[4]
Yoshida N, Ikemoto S, Narita K, et al. Interleukin-6, tumour necrosis factor alpha and interleukin-1 beta in patients with renal cell carcinoma. Br J Cancer,2002,86:1396 -1400.
[5]
Alexandrakis M G, Passam F H, Perisinakis K, et al. Serum proinflammatory cytokines and its relationship to clinical parameters in lung cancer patients with reactive thrombocytosis. Respir Med,2002,96:553 -558.
[6]
Jin L,Yuan R Q,Fuchs A,et al. Expression of interleukin-1 beta in human breast carcinoma. Cancer,1997,80:421 -434.
[7]
Pantschenko A G,Pushkar I, Anderson K H,et al. The interleukin-1 family of cytokines and receptors in human breast cancer:implications for tumor progression. Int J Oncol,2003,23:269 -284.
[8]
Dirix L Y, Dam P V, Prove A,et al. Inflammatory breast cancer: current understanding. Curr Opin Oncol,2006,18:563 -571.
[9]
Elaraj D M,Weinreich D M,Varghese S,et al. The role of interleukin-1 in growth and metastasis of human cancer xenografts. Cli Cancer Res,2006,12:1088 -1096.
[10]
Lee Y, Schwarz E, Davies M,et al. Differences in the cytokine profiles associated with prostate cancer cell induced osteoblastic and osteolytic lesions in bone. J Orthop Res,2003,21:62 -72.
[11]
Song X, Voronov E, Dvorkin E,et al. Differential effects of IL-1 alpha and IL-1 beta on tumorigenicity patterns and invasiveness. J Immunol,2003,171:6448 -6456.
[12]
Apte R N, Krelin Y, Song X, et al. Effects of micro-environment- and malignant cell-derived interleukin-1 in carcinogenesis,tumour invasiveness and tumour- host interactions. Eur J Cancer,2006,42:751 -759.
[13]
Seiji Y,Hiroshi N,Akihiko Y,et al. Multifunctional interleukin-1β promotes metastasis of human lung cancer cells in SCID mice via enhanced expression of adhesion-, invasiveness- and angiogenesis-related molecules. Cancer Sci,2003,94:244 -252.
[14]
Voronov E, Shouval D S, Krelin Y, et al. IL-1 is required for tumor invasiveness and angiogenesis. Proc Natl Acad Sci USA,2003,100:2645 -2650.
[15]
Shchors K,SHchors E, Rostker F,et al. The Myc-dependent angiogenic switch in tumors is mediated by interleukin-1 beta. Genes Dev,2006,20:2527 -2538.
[16]
Naomi K, Chikao M, Toshimichi Y,et al. Interleukin-1 receptor antagonist inhibits the expression of vascular endothelial growth factor in colorectal carcinoma. Oncology,2005,68:138 -145.
[17]
Hwang Y S, Jeong M, Park J S,et al. Interleukin-1β stimulates IL-8 expression through MAP kinase and ROS signaling in human gastric carcinoma cells. Oncogene,2004,23:6603 -6611.
[18]
Suswam E A, Nabors L B, Huang Y, et al. IL-1 beta induces stabilization of IL-8 mRNA in malignant breast cancer cells via the 3'untranslated region: Involvement of divergent RNA-binding factors HuR, KSRP and TIAR. Int J Cancer,2005,113:911 -919.
[19]
Hwang Y S, Jeong M, Park J S,et al. Interleukin-1 beta stimulates IL-8 expression through MAP kinase and ROS signaling in human gastric carcinoma cells. Oncogene,2004,23:6603 -6611.
[20]
Javier D, Manuel D, Díaz-Muoz, et al. Up-regulation of cyclooxygenase-2 by interleukin-1β in colon carcinoma cells. Cell Signal,2006,18:1262 -1269.
[21]
Kuwano T, Nakao S, Yamamoto H,et al. Cyclooxygenase 2 is a key enzyme for inflammatory cytokine-induced angiogenesis.FASEB J,2004,18:300 -310.
[22]
van Grevenstein W M, Holfland L J, Jeekel J,et al. The expression of adhesion molecules and the influence of inflammatory cytokines on the adhesion of human pancreatic carcinoma cells to mesothelial. Monolayers Pancreas,2006,32:396 -402.
[23]
Song G, Ohashi T, Sakamoto N,et al. Adhesive force of human hepatoma HepG2 cells to endothelial cells and expression of E-selectin. Mol Cell Biomech,2006,3:61 -68.
[24]
Deodutta R, Shubhashish S, Quentia F. Levels of IL-1 beta control stimulatory/inhibitory growth of cancer cells. Front Biosci,2006,11:889 -898.
[1] 王若岩, 贾琳娇, 孔舒欣, 范盼红, 王磊, 李文涛. 原发性肺癌乳腺转移一例[J/OL]. 中华乳腺病杂志(电子版), 2024, 18(04): 248-250.
[2] 刘银凤, 袁关利, 马力. PER基因家族在恶性肿瘤中的研究进展[J/OL]. 中华乳腺病杂志(电子版), 2024, 18(01): 40-46.
[3] 黄鸿初, 黄美容, 温丽红. 血液系统恶性肿瘤患者化疗后粒细胞缺乏感染的危险因素和风险预测模型[J/OL]. 中华实验和临床感染病杂志(电子版), 2024, 18(05): 285-292.
[4] 严华悦, 刘子祥, 周少波. 磷酸烯醇式丙酮酸羧激酶-1在恶性肿瘤中的研究进展[J/OL]. 中华普通外科学文献(电子版), 2024, 18(06): 452-456.
[5] 牛斌, 饶兰英, 娜迪拉·哈孜肯尼, 何龙林, 刘晓晨, 蒋波. 两样本孟德尔随机化分析阑尾切除与结直肠肛管恶性肿瘤发生风险的关系[J/OL]. 中华普通外科学文献(电子版), 2024, 18(01): 29-33.
[6] 晏晴艳, 雍晓梅, 罗洪, 杜敏. 成都地区老年转移性乳腺癌的预后及生存因素研究[J/OL]. 中华普外科手术学杂志(电子版), 2023, 17(06): 636-638.
[7] 张润锦, 阳盼, 林燕斯, 刘尊龙, 刘建平, 金小岩. EB病毒相关胆管癌伴多发转移一例及国内文献复习[J/OL]. 中华肝脏外科手术学电子杂志, 2024, 13(06): 865-869.
[8] 何慧玲, 鲁祖斌, 冯嘉莉, 梁声强. 术前外周血NLR和PLR对结肠癌术后肝转移的影响[J/OL]. 中华肝脏外科手术学电子杂志, 2024, 13(05): 682-687.
[9] 辛万鹏, 黄俊甫, 肖卫东. 机器人保留器官功能的胰腺切除术临床应用[J/OL]. 中华肝脏外科手术学电子杂志, 2024, 13(04): 461-465.
[10] 危用洋, 黄俊甫, 辛万鹏, 易思清, 涂书举, 方康, 李勇, 肖卫东. 三种术式治疗胰腺颈体部良性或低度恶性肿瘤的临床疗效分析[J/OL]. 中华肝脏外科手术学电子杂志, 2024, 13(04): 515-519.
[11] 陆思楠, 苏同荣, 张启逸. 索凡替尼转化治疗胰腺神经内分泌肿瘤肝转移一例并文献复习[J/OL]. 中华肝脏外科手术学电子杂志, 2024, 13(04): 526-530.
[12] 牛斌, 饶兰英, 刘晓晨, 何龙林, 秦培鑫. 基于孟德尔随机化分析胆囊切除与结直肠肛管恶性肿瘤发生的关系[J/OL]. 中华肝脏外科手术学电子杂志, 2024, 13(03): 313-318.
[13] 贺彬, 刘迅, 胡东辉. miR-107与恶性肿瘤的研究进展[J/OL]. 中华临床医师杂志(电子版), 2023, 17(10): 1117-1122.
[14] 王家圆, 王晓东. 消化系统恶性肿瘤相关肌少症的研究进展[J/OL]. 中华临床医师杂志(电子版), 2023, 17(07): 823-827.
[15] 王思奇, 张念荣, 周彪, 刘宝胤, 孟化. 肥胖与胆囊疾病研究进展[J/OL]. 中华肥胖与代谢病电子杂志, 2024, 10(03): 177-183.
阅读次数
全文


摘要